US scientists have found a way to reprogramme mature endothelial cells into mature adult stem cells.
Researchers at Harvard Medical School and the Harvard School of Dental Medicine found that the gene mutation that causes Fibrodysplasia Ossificans Progressiva also causes mature cells to revert to adult mesenchymal stem cells, which can differentiate into bone, cartilage, muscle, fat and even nerve cells.
Commenting on the study, Emerging Healthcare Solutions President and CEO Cindy Morrissey said that the research helps to make it conceivable that transplant patients may one day have some of their own cells extracted, reprogrammed and grown into the desired tissue type they need.
“We will see more breakthroughs such as this emerge as more and more stem-cell research is funded and carried out,” Morrissey added.
Fibrodysplasia Ossificans Progressiva is a rare and progressive disease that causes soft tissue to mutate into cartilage and bone.